Kim, Joo Hyun <br/><br/>
PKD1 is critical for Epstein-Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximab.  [electronic resource] 

 -  Leukemia & lymphoma  Jan 2015 
 - 194-201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2014.911860  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Murine-Derived--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Enzyme Activation<br/>Gene Expression<br/>Gene Knockdown Techniques<br/>Humans<br/>Lymphoma, B-Cell--genetics<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Protein Binding<br/>Protein Transport<br/>Rituximab<br/>TRPP Cation Channels--genetics<br/>Viral Matrix Proteins--genetics